The global market of Vitamin B* has maintained a steady pricing environment across key regions in May ****. This market trend was result of calculated interplay between stable procurement cycles from downstream sectors and strategic inventory positioning by suppliers. The core application industries like pharmaceuticals, nutraceuticals, personal care and food & beverage have maintained predictable offtake schedules that aligned with their production forecasts.
The Vitamin B* suppliers have avoided speculative excessive stockpiling and preserved a steady market structure. The bearish sentiment in the global maize market has contributed to this price stability. This trend indirectly influenced glucose-based biofermentation costs for Vitamin B*. The resilience of demand from health-focused sectors have ensured that Vitamin B* prices moved within a narrow and managed range without disruptive volatility.
The Vitamin B* market in China has reported a *.*** increase in FOB Shanghai prices...
